|
CN112142716A
|
|
5-membered heteroaryl substituted pyrazine derivative and application thereof
|
|
CN111138542A
|
|
Bispecific antibodies and uses thereof
|
|
CN111377857A
|
|
Method for synthesizing milrinone
|
|
CN109438371A
|
|
A kind of methylpyrazine derivative arginine hydrate
|
|
CN109438372A
|
|
A kind of methylpyrazine derivative methanol solvate
|
|
CN111378001A
|
|
Cycloastragenol crystal form E and preparation method thereof
|
|
CN111380974A
|
|
Detection method of echinocandin
|
|
CN111377981A
|
|
5-deoxy-D-ribose derivative
|
|
CN111374942A
|
|
Steroid muscle relaxant injection and preparation method thereof
|
|
CN111377989A
|
|
Preparation method of decitabine intermediate
|
|
CN109400540A
|
|
A kind of niacinamide methylpyrazine derivative eutectic A
|
|
CN111378003A
|
|
Cycloastragenol crystal form G and preparation method thereof
|
|
CN109400539A
|
|
A kind of methylpyrazine derivative semihydrate
|
|
CN111378002A
|
|
Novel cycloastragenol crystal form A and preparation method thereof
|
|
CN109369546A
|
|
A kind of methylpyrazine derivative theophylline semihydrate
|
|
CN111377858A
|
|
Preparation method of milrinone
|
|
CN109438370A
|
|
A kind of methylpyrazine derivative anhydrous crystal forms
|
|
CN109503475A
|
|
A kind of Pyrazinamide methylpyrazine derivative eutectic I
|
|
CN111377851A
|
|
Preparation method of levamlodipine besylate
|
|
CN111377986A
|
|
Method for purifying decitabine intermediate
|
